BME News

February 9, 2024

EMBRIO Institute comes to High Alpha in Indianapolis

Krishna Jayant, assistant professor in the Weldon School of Biomedical Engineering at Purdue, presents his group’s research to other researchers from multiple disciplines during the two-day EMBRIO institute retreat at High Alpha in Indianapolis. The slide highlights the work Jayant and student Shulan Xiao are doing to “uncover the rules via which neurons multiplex information across multiple dendrites.”
January 31, 2024

Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment

Adipo is a privately held, late-stage, preclinical biopharmaceutical company developing a breakthrough approach to treat the dual epidemics of obesity and Type 2 diabetes. Adipo has identified a lead asset, ADPO-002, that combines a notch inhibitor with novel nanoparticle technology. ADPO-002 is specifically designed to infiltrate and release the active ingredient inside the cellular structure of white adipose tissue, which results in mitochondrial biogenesis and the beiging of white adipose tissue. Meng Deng is the founder and president of Adipo Therapeutics. He also is an associate professor in Purdue University’s Department of Agricultural and Biological Engineering, Weldon School of Biomedical Engineering and School of Materials Engineering.
January 30, 2024

Faculty Spotlight: Steve Steinhubl, MD

He may be an MD, not a PhD, but his research on the development of individualized digital biomarkers made possible by wearable sensors may change the face of healthcare.
January 23, 2024

BME's Lee receives patent

Hyowon (Hugh) Lee, an associate professor in the Weldon School of Biomedical Engineering, for receiving a patent on his intellectual property, “Drug Delivery Device and Method.”
< Previous 10 | Viewing 31 to 40 of 1322 | Next 10 >